The effect of lignocaine on pain outcomes for women undergoing gynaecological surgery for chronic pelvic pai
- Conditions
- Chronic pelvic painAnaesthesiology - Pain managementRenal and Urogenital - Other renal and urogenital disordersSurgery - Other surgery
- Registration Number
- ACTRN12621000589886
- Lead Sponsor
- Monash health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 70
Women requiring elective operative gynaecological laparoscopy for benign indication as determined and agreed by both the surgeon and the participant.
- Experience of pelvic pain on most days in the preceding 6 months
- Over 18years old and premenopausal at the time of the surgery.
- Participants who understand the conditions of the study and are willing to participate for the duration of study including all follow-up.
- Participants who are capable of, and have given, informed consent to their participation in the study.
- English language or an available translator sufficient to complete the validated quality of life instruments.
- Surgery at Moorabbin Hospital under specialised Endosurgery unit
- Contraindications to lignocaine (Hypersensitivity; Myasthenia gravis; Severe shock; Supraventricular arrhythmia; Impaired cardiac conduction; Stokes-Adams syndrome or severe degrees of sinoatrial, atrioventricular or intraventricular heart block unless the participant has an artificial pacemaker; Severe renal or liver disease; Use of beta blocker medication e.g. propranolol, metoprolol, atenolol, bisoprolol; Use of Anti-arrhythmic medication e.g. amiodarone, flecainide sotalol, digoxin; Electrolyte abnormalities)
- No significant and persisting pain component to presentation in preceding 6 months.
- Known or suspected malignancy
- Pregnancy
- Requirement for alternative analgesia regimen
- Current/recent use of methadone within 6months of surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method